Abstract
(Abstracted from JAMA 2019;322(7):652–665) For women in the United States, BRCA1/2 mutations occur in approximately 1 in 300 to 500 women. Risk of ovarian, fallopian, and peritoneal cancer is also increased to 39% in those with BRCA1 mutations and 10% to 17% for those with BRCA2 mutations.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
